JP2011503064A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011503064A5 JP2011503064A5 JP2010533099A JP2010533099A JP2011503064A5 JP 2011503064 A5 JP2011503064 A5 JP 2011503064A5 JP 2010533099 A JP2010533099 A JP 2010533099A JP 2010533099 A JP2010533099 A JP 2010533099A JP 2011503064 A5 JP2011503064 A5 JP 2011503064A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- cells
- weeks
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 32
- 210000004027 cells Anatomy 0.000 claims 16
- 230000003169 placental Effects 0.000 claims 15
- 210000000130 stem cell Anatomy 0.000 claims 14
- 230000002028 premature Effects 0.000 claims 12
- 210000004700 Fetal Blood Anatomy 0.000 claims 10
- 210000002826 Placenta Anatomy 0.000 claims 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 6
- 102000003951 Erythropoietin Human genes 0.000 claims 5
- 108090000394 Erythropoietin Proteins 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 229940105423 erythropoietin Drugs 0.000 claims 5
- 102100016492 CD34 Human genes 0.000 claims 4
- 108060001251 CD34 Proteins 0.000 claims 4
- 206010036590 Premature baby Diseases 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 238000005755 formation reaction Methods 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 3
- 210000003743 Erythrocytes Anatomy 0.000 claims 3
- 102100017063 NT5E Human genes 0.000 claims 3
- 101710039712 NT5E Proteins 0.000 claims 3
- 210000003324 RBC Anatomy 0.000 claims 3
- 229910052742 iron Inorganic materials 0.000 claims 3
- 210000004369 Blood Anatomy 0.000 claims 2
- 102100003404 HLA-G Human genes 0.000 claims 2
- 108010024164 HLA-G Antigens Proteins 0.000 claims 2
- 208000005107 Premature Birth Diseases 0.000 claims 2
- 229960002477 Riboflavin Drugs 0.000 claims 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive Effects 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 2
- 210000000056 organs Anatomy 0.000 claims 2
- 230000035935 pregnancy Effects 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 229930003231 vitamins Natural products 0.000 claims 2
- 208000007502 Anemia Diseases 0.000 claims 1
- 208000008784 Apnea Diseases 0.000 claims 1
- 206010002974 Apnoea Diseases 0.000 claims 1
- 210000004556 Brain Anatomy 0.000 claims 1
- 206010006475 Bronchopulmonary dysplasia Diseases 0.000 claims 1
- 210000001508 Eye Anatomy 0.000 claims 1
- 229960000304 Folic Acid Drugs 0.000 claims 1
- 230000036499 Half live Effects 0.000 claims 1
- 210000002216 Heart Anatomy 0.000 claims 1
- 206010020578 Hyperbilirubinaemia Diseases 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 claims 1
- 210000000987 Immune System Anatomy 0.000 claims 1
- 206010022840 Intraventricular haemorrhage Diseases 0.000 claims 1
- 210000003734 Kidney Anatomy 0.000 claims 1
- 210000000265 Leukocytes Anatomy 0.000 claims 1
- 210000004185 Liver Anatomy 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 208000009856 Lung Disease Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010051606 Necrotising colitis Diseases 0.000 claims 1
- 208000004995 Necrotizing Enterocolitis Diseases 0.000 claims 1
- 208000003278 Patent Ductus Arteriosus Diseases 0.000 claims 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 claims 1
- AUNGANRZJHBGPY-OUCADQQQSA-N Riboflavin Natural products OC[C@@H](O)[C@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-OUCADQQQSA-N 0.000 claims 1
- 210000002966 Serum Anatomy 0.000 claims 1
- 229940029983 VITAMINS Drugs 0.000 claims 1
- 229940088594 Vitamin Drugs 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229930003471 Vitamin B2 Natural products 0.000 claims 1
- 229930003629 Vitamin B6 Natural products 0.000 claims 1
- 229940011671 Vitamin B6 Drugs 0.000 claims 1
- 229940046009 Vitamin E Drugs 0.000 claims 1
- 229930003427 Vitamin E Natural products 0.000 claims 1
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims 1
- 201000004532 bilirubin metabolic disease Diseases 0.000 claims 1
- 230000001684 chronic Effects 0.000 claims 1
- 125000003346 cobalamin group Chemical group 0.000 claims 1
- 201000009910 diseases by infectious agent Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000019152 folic acid Nutrition 0.000 claims 1
- 239000011724 folic acid Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 230000000926 neurological Effects 0.000 claims 1
- 230000032696 parturition Effects 0.000 claims 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 claims 1
- 229960002862 pyridoxine Drugs 0.000 claims 1
- 235000008160 pyridoxine Nutrition 0.000 claims 1
- 239000011677 pyridoxine Substances 0.000 claims 1
- 235000019192 riboflavin Nutrition 0.000 claims 1
- 239000002151 riboflavin Substances 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 235000019164 vitamin B2 Nutrition 0.000 claims 1
- 239000011716 vitamin B2 Substances 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 239000011726 vitamin B6 Substances 0.000 claims 1
- 150000003697 vitamin B6 derivatives Chemical class 0.000 claims 1
- 235000019165 vitamin E Nutrition 0.000 claims 1
- 239000011709 vitamin E Substances 0.000 claims 1
- 150000003712 vitamin E derivatives Chemical class 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Claims (32)
- 臍帯血および胎盤幹細胞を含む、未熟児の障害または状態を治療するための医薬組成物であって、前記障害または状態が早産によって引き起こされるまたは早産に伴うものである、医薬組成物。
- 血液添加剤をさらに含み、前記血液添加剤は、エリスロポエチン、鉄補充物質、ビタミン、または臍帯血以外の供給源由来の赤血球である、請求項1に記載の医薬組成物。
- 前記エリスロポエチンが、組換えエリスロポエチンである、請求項2に記載の医薬組成物。
- 前記組換えエリスロポエチンは、天然のエリスロポエチンと比較して、血清半減期が延長されるように遺伝子操作されている、請求項3に記載の医薬組成物。
- 前記ビタミンが、リボフラビン(ビタミンB2)、ピリドキシン(ビタミンB6)、葉酸、ビタミンB12またはビタミンEである、請求項2に記載の医薬組成物。
- 前記鉄補充物質が、元素鉄(elemental iron)である、請求項2に記載の医薬組成物。
- 前記赤血球が、少なくとも2500cGyの放射線を照射されたものである、請求項2に記載の医薬組成物。
- 前記赤血球から、白血球が除去されている、請求項2に記載の医薬組成物。
- 前記未熟児が、出生時に妊娠約23〜約25週、約26〜約29週、約30〜約33週または約34〜約37週を経ている、請求項1に記載の医薬組成物。
- 出生時の前記未熟児の体重が、約800グラム以上、約500グラム〜約800グラムまたは約500グラム未満である、請求項1に記載の医薬組成物。
- 前記障害または状態が、呼吸促迫症候群(RDS)、急性呼吸促迫症候群(ARDS)、貧血、神経学的な欠損、脳室内出血、壊死性腸炎、未熟児網膜症、慢性肺疾患(気管支肺異形成症)、感染症、動脈管開存、無呼吸、低血圧、高ビリルビン血症または臓器の不完全な発達によって引き起こされる障害もしくは状態である、請求項1に記載の医薬組成物。
- 前記臓器が、肺、眼、免疫系、脳、心臓、肝臓または腎臓である、請求項11に記載の医薬組成物。
- 前記臍帯血が、未熟児にとって自己由来である、請求項1に記載の医薬組成物。
- 胎盤幹細胞が、未熟児にとって自己由来である、請求項1に記載の医薬組成物。
- 前記臍帯血が、正期産分娩後の哺乳動物の胎盤から得られたものである、請求項1に記載の医薬組成物。
- 前記臍帯血が、早産分娩後の哺乳動物の胎盤から得られたものである、請求項1に記載の医薬組成物。
- 前記胎盤が、前記未熟児の胎盤である、請求項16に記載の医薬組成物。
- 前記胎盤が、妊娠約23〜約25週、約26〜約29週、約30〜約33週または約34〜約37週で出生した乳児の胎盤である、請求項17に記載の医薬組成物。
- 前記臍帯血が、臍帯血バンクから得られたものである、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞が、胎盤灌流液から単離された幹細胞または胎盤灌流液内に含有される幹細胞である、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞が、CD34+細胞;CD34 − 細胞;OCT−4 + 細胞;CD73 + 、CD105 + およびCD200 + である細胞;CD200 + もしくはHLA−G + である細胞;CD200 + およびOCT−4 + である細胞;または、CD73 + 、CD105 + およびHLA−G + である細胞を含む、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞には、CD73+およびCD105+である細胞であって、前記細胞を含む胎盤細胞集団を、胚様体様の物体の形成を可能にする条件下で培養する場合、前記集団中における1つまたは複数の胚様体様の物体の形成を促進する細胞が含まれる、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞には、OCT−4+である細胞であって、前記幹細胞を含む胎盤細胞集団を、胚様体様の物体の形成を可能にする条件下で培養する場合、前記集団中における1つまたは複数の胚様体様の物体の形成を促進する細胞が含まれる、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞が、正期産分娩後または早産分娩後の哺乳動物の胎盤から得られる、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞が、前記未熟児の胎盤から得られる、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞が、妊娠約23〜約25週、約26〜約29週、約30〜約33週または約34〜約37週で出生した乳児の胎盤から得られる、請求項1に記載の医薬組成物。
- 前記臍帯血または前記胎盤幹細胞は免疫型が決定されていないものである、請求項1に記載の医薬組成物。
- 前記組成物は、前記未熟児に対し、前記未熟児の出生後1回または複数回投与してよいものである、請求項1に記載の医薬組成物。
- 前記組成物は、前記未熟児に対し、前記未熟児の出生後1時間以内、12時間以内、24時間以内または1週間以内に投与してよいものである、請求項1に記載の医薬組成物。
- 前記臍帯血が、前記未熟児の体重1キログラム当たり約1×105〜約1×106個のCD34+細胞を含む、請求項1に記載の医薬組成物。
- 前記胎盤幹細胞および前記臍帯血が併せて、前記未熟児の体重1キログラム当たり約1×105〜約1×106個のCD34+細胞を含む、請求項1に記載の医薬組成物。
-
前記組成物は、静脈内注射により投与してよいものである、請求項1に記載の医薬組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US237507P | 2007-11-07 | 2007-11-07 | |
PCT/US2008/012540 WO2009061447A2 (en) | 2007-11-07 | 2008-11-07 | Treatment of premature birth complications |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015006887A Division JP2015120713A (ja) | 2007-11-07 | 2015-01-16 | 早産の合併症の治療 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011503064A JP2011503064A (ja) | 2011-01-27 |
JP2011503064A5 true JP2011503064A5 (ja) | 2011-12-22 |
Family
ID=40626389
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010533099A Pending JP2011503064A (ja) | 2007-11-07 | 2008-11-07 | 早産の合併症の治療 |
JP2015006887A Withdrawn JP2015120713A (ja) | 2007-11-07 | 2015-01-16 | 早産の合併症の治療 |
JP2016118867A Withdrawn JP2016216470A (ja) | 2007-11-07 | 2016-06-15 | 早産の合併症の治療 |
JP2017201820A Withdrawn JP2018052944A (ja) | 2007-11-07 | 2017-10-18 | 早産の合併症の治療 |
JP2019143026A Withdrawn JP2019218366A (ja) | 2007-11-07 | 2019-08-02 | 早産の合併症の治療 |
JP2022019526A Pending JP2022070952A (ja) | 2007-11-07 | 2022-02-10 | 早産の合併症の治療 |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015006887A Withdrawn JP2015120713A (ja) | 2007-11-07 | 2015-01-16 | 早産の合併症の治療 |
JP2016118867A Withdrawn JP2016216470A (ja) | 2007-11-07 | 2016-06-15 | 早産の合併症の治療 |
JP2017201820A Withdrawn JP2018052944A (ja) | 2007-11-07 | 2017-10-18 | 早産の合併症の治療 |
JP2019143026A Withdrawn JP2019218366A (ja) | 2007-11-07 | 2019-08-02 | 早産の合併症の治療 |
JP2022019526A Pending JP2022070952A (ja) | 2007-11-07 | 2022-02-10 | 早産の合併症の治療 |
Country Status (16)
Country | Link |
---|---|
US (4) | US20090136471A1 (ja) |
EP (2) | EP2217329B1 (ja) |
JP (6) | JP2011503064A (ja) |
KR (8) | KR20170116221A (ja) |
CN (2) | CN101909694A (ja) |
AU (1) | AU2008325142A1 (ja) |
CA (1) | CA2704746A1 (ja) |
DK (1) | DK2217329T3 (ja) |
ES (1) | ES2667210T3 (ja) |
HK (2) | HK1232146A1 (ja) |
IL (1) | IL205595A0 (ja) |
MX (1) | MX2010005018A (ja) |
NO (1) | NO2217329T3 (ja) |
RU (1) | RU2010123002A (ja) |
WO (1) | WO2009061447A2 (ja) |
ZA (1) | ZA201003057B (ja) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
CA2430989A1 (en) | 2000-12-06 | 2002-06-13 | Robert J. Hariri | Method of collecting placental stem cells |
EP3246396B1 (en) * | 2001-02-14 | 2020-01-29 | Celularity, Inc. | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US7682803B2 (en) * | 2005-10-13 | 2010-03-23 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
KR20050086780A (ko) * | 2002-11-26 | 2005-08-30 | 안트로제네시스 코포레이션 | 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법 |
JP2007531116A (ja) * | 2004-03-26 | 2007-11-01 | セルジーン・コーポレーション | 幹細胞バンクを提供するためのシステム及び方法 |
KR20080056302A (ko) * | 2005-10-13 | 2008-06-20 | 안트로제네시스 코포레이션 | 태반 유래 줄기세포로부터 생산된 희소돌기 아교세포 |
US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
KR20180105266A (ko) | 2005-12-29 | 2018-09-27 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
AU2006332679A1 (en) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
US8562972B2 (en) | 2006-10-23 | 2013-10-22 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
KR20090109127A (ko) * | 2007-02-12 | 2009-10-19 | 안트로제네시스 코포레이션 | 부착성 태반 줄기세포에서 유래한 간세포와 연골세포 및 cd34+, cd45- 태반 줄기세포가 농축된 세포군 |
AU2008216749B2 (en) | 2007-02-12 | 2014-03-13 | Celularity Inc. | Treatment of inflammatory diseases using placental stem cells |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
SI2203176T1 (sl) | 2007-09-28 | 2015-04-30 | Anthrogenesis Corporation | Tumorska supresija z uporabo humanega perfuzata placente in intermediarnih naravnih celic ubijalk, pridobljenih iz humane placente |
KR20170116221A (ko) * | 2007-11-07 | 2017-10-18 | 안트로제네시스 코포레이션 | 조산 합병증의 치료에 있어서의 제대혈의 용도 |
CN105766891A (zh) | 2008-08-20 | 2016-07-20 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
AU2009283161A1 (en) | 2008-08-22 | 2010-02-25 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
WO2010026574A2 (en) * | 2008-09-02 | 2010-03-11 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
RU2562154C2 (ru) | 2008-11-19 | 2015-09-10 | Антродженезис Корпорейшн | Амниотические адгезивные клетки |
WO2011002959A1 (en) | 2009-07-02 | 2011-01-06 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
JP2013518108A (ja) | 2010-01-26 | 2013-05-20 | アントフロゲネシス コーポレーション | 胎盤幹細胞を用いる骨関連癌の治療 |
TW201703777A (zh) | 2010-04-07 | 2017-02-01 | 安瑟吉納西斯公司 | 利用胎盤幹細胞之血管新生 |
KR20130092394A (ko) | 2010-04-08 | 2013-08-20 | 안트로제네시스 코포레이션 | 태반 줄기 세포를 사용한 사르코이드증의 치료 |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
WO2012003960A1 (en) * | 2010-07-06 | 2012-01-12 | Augustinus Bader | Topical application of erythropoietin for the treatment of eye disorders and injuries |
KR20210063457A (ko) | 2010-07-13 | 2021-06-01 | 안트로제네시스 코포레이션 | 천연 킬러 세포의 생성 방법 |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
PT2714059T (pt) | 2011-06-01 | 2019-02-04 | Celularity Inc | Tratamento da dor utilizando células estaminais da placenta |
US10190092B2 (en) | 2011-08-11 | 2019-01-29 | Robert A. Dracker | Procurement of placental stem cells |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
US20130216502A1 (en) * | 2012-02-22 | 2013-08-22 | Nationwide Children's Hospital Inc. | Methods of Treating Intestinal Injury Using Heparin Binding Epidermal Growth Factor and Stem Cells |
KR101405620B1 (ko) | 2012-09-07 | 2014-06-10 | 사회복지법인 삼성생명공익재단 | 중간엽 줄기세포를 포함하는 미숙아 뇌실 내 출혈 치료용 조성물 |
EP2953635A4 (en) | 2013-02-05 | 2016-10-26 | Anthrogenesis Corp | NATURAL KILLER CELLS FROM PLAZENTA |
RU2676303C2 (ru) * | 2013-07-11 | 2018-12-27 | Новартис Аг | Использование антагониста vegf для лечения ретролентальной фиброплазии |
CN103756965B (zh) * | 2014-01-27 | 2016-04-06 | 山东省齐鲁干细胞工程有限公司 | 一种从胎盘中灌洗造血干细胞的方法 |
WO2015164233A1 (en) * | 2014-04-21 | 2015-10-29 | Anthrogenesis Corporation | Treatment of conditions and complications in infants |
US20160158292A1 (en) * | 2014-07-29 | 2016-06-09 | Ingeneron, Inc. | Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof |
US10584370B2 (en) | 2014-12-16 | 2020-03-10 | Soft Cell Biological Research, Llc | Screening for L-form bacteria |
CA2986702C (en) | 2015-05-21 | 2023-04-04 | David Wang | Modified demineralized cortical bone fibers |
RU2624253C1 (ru) * | 2016-03-17 | 2017-07-03 | Федеральное государственное бюджетное учреждение "Научный центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Метод заготовки и применения аутологичных эритроцитов из пуповинной крови для коррекции анемии у новорожденных |
US20180274005A1 (en) * | 2017-03-24 | 2018-09-27 | Soft Cell Biological Research, Llc | Cord blood therapy to treat chronic disease caused by l-form bacteria |
CN111514392A (zh) * | 2020-04-29 | 2020-08-11 | 广州市天河诺亚生物工程有限公司 | 一种可用于预防早产儿并发症的自体脐带血处理方法及其应用 |
CN113332507A (zh) * | 2021-06-11 | 2021-09-03 | 广东省妇幼保健院 | 一种脐带血采集方法及其应用 |
WO2023172960A1 (en) * | 2022-03-09 | 2023-09-14 | The Children's Hospital Of Philadelphia | System and method of treatment for premature fetus |
Family Cites Families (106)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US4798824A (en) * | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US4796605A (en) * | 1986-07-11 | 1989-01-10 | Atom Kabushiki Kaisha | Incubator |
US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
US5284766A (en) * | 1989-02-10 | 1994-02-08 | Kao Corporation | Bed material for cell culture |
US5272263A (en) * | 1989-04-28 | 1993-12-21 | Biogen, Inc. | DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
US5356373A (en) * | 1991-11-15 | 1994-10-18 | Miles Inc. | Method and apparatus for autologous transfusions in premature infants |
RU2155066C2 (ru) * | 1993-03-31 | 2000-08-27 | Про-Ньюрон, Инк. | Ингибитор пролиферации стволовых клеток и его использование |
US5709854A (en) | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5698579A (en) * | 1993-07-02 | 1997-12-16 | Celgene Corporation | Cyclic amides |
US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
DK0952792T3 (da) * | 1994-06-06 | 2003-12-08 | Osiris Therapeutics Inc | Biomatrix til vævsregeneration |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5516532A (en) | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
MX9701512A (es) * | 1994-11-16 | 1997-05-31 | Amgen Inc | Uso del factor de celulas madre y receptor de interleucina-6 soluble para la expansion ex vivo de celulas multipotenciales hematopoyeticas. |
US5874301A (en) * | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5728306A (en) | 1994-12-23 | 1998-03-17 | Baxter International Inc. | Leukodepletion filter and method for filtering leukocytes from freshly drawn blood |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
AU716889B2 (en) * | 1995-11-17 | 2000-03-09 | Asahi Kasei Kogyo Kabushiki Kaisha | Differentiation-suppressive polypeptide |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
EP2311471A3 (en) * | 1996-04-19 | 2013-05-15 | Osiris Therapeutics, Inc. | Regeneration and augmentation of bone using mesenchymal stem cells |
US5919176A (en) * | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US6281230B1 (en) * | 1996-07-24 | 2001-08-28 | Celgene Corporation | Isoindolines, method of use, and pharmaceutical compositions |
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US6358737B1 (en) * | 1996-07-31 | 2002-03-19 | Board Of Regents, The University Of Texas System | Osteocyte cell lines |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
WO1999011287A1 (en) * | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
US5874448A (en) * | 1997-11-18 | 1999-02-23 | Celgene Corporation | Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels |
ATE286118T1 (de) * | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
US6030836A (en) * | 1998-06-08 | 2000-02-29 | Osiris Therapeutics, Inc. | Vitro maintenance of hematopoietic stem cells |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6102871A (en) | 1998-11-23 | 2000-08-15 | Coe; Rosemarie O. | Blood collection funnel |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
AU4860900A (en) | 1999-06-02 | 2000-12-18 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US6852698B2 (en) * | 2000-01-18 | 2005-02-08 | Irina A. Buhimschi | Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition |
AU4346401A (en) * | 2000-03-09 | 2001-09-17 | Cryo Cell Int | Human cord blood as a source of neural tissue for repair of the brain and spinalcord |
US7282366B2 (en) * | 2000-04-27 | 2007-10-16 | Geron Corporation | Hepatocytes for therapy and drug screening made from embryonic stem cells |
US20050009876A1 (en) * | 2000-07-31 | 2005-01-13 | Bhagwat Shripad S. | Indazole compounds, compositions thereof and methods of treatment therewith |
US6818216B2 (en) * | 2000-11-28 | 2004-11-16 | Medimmune, Inc. | Anti-RSV antibodies |
AU3956002A (en) * | 2000-11-28 | 2002-06-11 | Childrens Medical Center | Determination of risk and treatment of complications of prematurity |
CA2430989A1 (en) * | 2000-12-06 | 2002-06-13 | Robert J. Hariri | Method of collecting placental stem cells |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
AU2002251935B2 (en) * | 2001-02-14 | 2007-11-29 | Celularity Inc. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
EP3246396B1 (en) * | 2001-02-14 | 2020-01-29 | Celularity, Inc. | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US20030044977A1 (en) * | 2001-08-10 | 2003-03-06 | Norio Sakuragawa | Human stem cells originated from human amniotic mesenchymal cell layer |
WO2003061591A2 (en) * | 2002-01-22 | 2003-07-31 | Advanced Cell Technology, Inc. | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
US7682803B2 (en) * | 2005-10-13 | 2010-03-23 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
AU2003216286B2 (en) * | 2002-02-13 | 2008-08-28 | Celularity Inc. | Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
JP2005528105A (ja) * | 2002-05-30 | 2005-09-22 | セルジーン・コーポレーション | 細胞分化をモジュレートするため、並びに骨髄増殖性疾患及び骨髄異形成症候群を治療するためのjnk又はmkk阻害剤の使用方法 |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
JP2006517975A (ja) * | 2003-02-13 | 2006-08-03 | アンスロジェネシス コーポレーション | 疾患、障害または症状を患っている個体を治療するための臍帯血の使用 |
PL1641914T3 (pl) * | 2003-06-27 | 2017-01-31 | DePuy Synthes Products, Inc. | Komórki pochodzące z poporodowej tkanki łożyska oraz sposoby uzyskiwania i zastosowania tych komórek |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
AU2004293443A1 (en) * | 2003-11-19 | 2005-06-09 | Signal Pharmaceuticals, Llc. | Indazole Compounds and methods of use thereof as protein kinase inhibitors |
US7909806B2 (en) * | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
US9056093B2 (en) * | 2005-01-07 | 2015-06-16 | Wake Forest University Health Sciences | Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
US20060236456A1 (en) * | 2005-03-03 | 2006-10-26 | Beale Robert S | Patient transport method and apparatus |
NZ564563A (en) * | 2005-06-10 | 2011-03-31 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
KR20080026198A (ko) * | 2005-06-30 | 2008-03-24 | 안트로제네시스 코포레이션 | 태반 유도된 콜라겐 바이오패브릭을 사용한 고막의 복원 |
US20070021762A1 (en) * | 2005-07-13 | 2007-01-25 | Qing Liu | Ocular plug formed from placenta derived collagen biofabric |
US7928280B2 (en) * | 2005-07-13 | 2011-04-19 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
WO2007011693A2 (en) * | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions of placentally-derived stem cells for the treatment of cancer |
KR20080056302A (ko) * | 2005-10-13 | 2008-06-20 | 안트로제네시스 코포레이션 | 태반 유래 줄기세포로부터 생산된 희소돌기 아교세포 |
KR100697326B1 (ko) * | 2005-12-02 | 2007-03-20 | 재단법인서울대학교산학협력재단 | Oct4 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법 |
EP1979050B1 (en) * | 2005-12-28 | 2017-04-19 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using postpartum-derived cells |
KR20180105266A (ko) * | 2005-12-29 | 2018-09-27 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
WO2007100560A2 (en) * | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b |
US20090274665A1 (en) * | 2006-04-27 | 2009-11-05 | Cell Therapy Technologies, Inc. | Stem Cells For Treating Lung Diseases |
KR20090031895A (ko) * | 2006-06-09 | 2009-03-30 | 안트로제네시스 코포레이션 | 태반 니치 및 줄기 세포 배양을 위한 이의 용도 |
US8105634B2 (en) * | 2006-08-15 | 2012-01-31 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
KR20170116221A (ko) * | 2007-11-07 | 2017-10-18 | 안트로제네시스 코포레이션 | 조산 합병증의 치료에 있어서의 제대혈의 용도 |
PE20110399A1 (es) * | 2008-08-20 | 2011-06-22 | Anthrogenesis Corp | Tratamiento de la apoplejia utilizando celulas placentarias aisladas |
CN105766891A (zh) * | 2008-08-20 | 2016-07-20 | 人类起源公司 | 改进的细胞组合物及制备所述组合物的方法 |
AU2009283161A1 (en) * | 2008-08-22 | 2010-02-25 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US9168273B2 (en) * | 2009-03-05 | 2015-10-27 | Robert A. Dracker | Intrathecal administration of autologous stem cells to treat intraventricular hemorrhage in premature infants |
US20110294879A1 (en) * | 2010-05-28 | 2011-12-01 | Xenoport, Inc. | Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders |
-
2008
- 2008-11-07 KR KR1020177027637A patent/KR20170116221A/ko not_active Application Discontinuation
- 2008-11-07 KR KR1020227022506A patent/KR20220098055A/ko not_active Application Discontinuation
- 2008-11-07 CN CN200880123939XA patent/CN101909694A/zh active Pending
- 2008-11-07 ES ES08847846.6T patent/ES2667210T3/es active Active
- 2008-11-07 RU RU2010123002/15A patent/RU2010123002A/ru not_active Application Discontinuation
- 2008-11-07 EP EP08847846.6A patent/EP2217329B1/en active Active
- 2008-11-07 NO NO08847846A patent/NO2217329T3/no unknown
- 2008-11-07 JP JP2010533099A patent/JP2011503064A/ja active Pending
- 2008-11-07 AU AU2008325142A patent/AU2008325142A1/en not_active Abandoned
- 2008-11-07 MX MX2010005018A patent/MX2010005018A/es not_active Application Discontinuation
- 2008-11-07 WO PCT/US2008/012540 patent/WO2009061447A2/en active Application Filing
- 2008-11-07 CN CN201610806430.1A patent/CN106214702A/zh active Pending
- 2008-11-07 DK DK08847846.6T patent/DK2217329T3/en active
- 2008-11-07 KR KR1020107012277A patent/KR20100100855A/ko not_active Application Discontinuation
- 2008-11-07 US US12/267,499 patent/US20090136471A1/en not_active Abandoned
- 2008-11-07 KR KR1020197000096A patent/KR20190004832A/ko not_active Application Discontinuation
- 2008-11-07 CA CA2704746A patent/CA2704746A1/en not_active Withdrawn
- 2008-11-07 KR KR1020167008450A patent/KR20160040739A/ko not_active Application Discontinuation
- 2008-11-07 KR KR1020217013845A patent/KR20210056449A/ko not_active Application Discontinuation
- 2008-11-07 EP EP17202323.6A patent/EP3345609A1/en not_active Withdrawn
- 2008-11-07 KR KR1020237007120A patent/KR20230035451A/ko not_active Application Discontinuation
- 2008-11-07 KR KR1020207006482A patent/KR20200028045A/ko not_active Application Discontinuation
-
2010
- 2010-04-30 ZA ZA2010/03057A patent/ZA201003057B/en unknown
- 2010-05-06 IL IL205595A patent/IL205595A0/en unknown
-
2012
- 2012-10-12 US US13/650,803 patent/US20130259845A1/en not_active Abandoned
-
2015
- 2015-01-16 JP JP2015006887A patent/JP2015120713A/ja not_active Withdrawn
-
2016
- 2016-06-15 JP JP2016118867A patent/JP2016216470A/ja not_active Withdrawn
-
2017
- 2017-06-13 HK HK17105867.0A patent/HK1232146A1/zh unknown
- 2017-10-18 JP JP2017201820A patent/JP2018052944A/ja not_active Withdrawn
-
2018
- 2018-12-24 HK HK18116496.5A patent/HK1257536A1/zh unknown
-
2019
- 2019-05-30 US US16/427,223 patent/US20190321413A1/en not_active Abandoned
- 2019-08-02 JP JP2019143026A patent/JP2019218366A/ja not_active Withdrawn
-
2022
- 2022-02-10 JP JP2022019526A patent/JP2022070952A/ja active Pending
- 2022-11-21 US US18/057,487 patent/US20230090316A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2011503064A5 (ja) | ||
JP2018052944A5 (ja) | ||
RU2010123002A (ru) | Лечение осложнений преждевременных родов | |
JP2021020908A (ja) | エキソソームに関連する方法および組成物 | |
JP6796143B2 (ja) | トロンビン処理幹細胞に由来するエキソソームを含む慢性肺疾患治療用組成物 | |
JP5950577B2 (ja) | 単離胎盤細胞を使用した脳卒中の治療 | |
Tolosa et al. | Mankind’s first natural stem cell transplant | |
WO2017204231A1 (ja) | 臍帯由来細胞を含む脳障害の治療剤 | |
AU2011352154A1 (en) | Methods for cryopreserving and encapsulating cells | |
JP2016500114A (ja) | 哺乳類の幹細胞に作用する方法と、哺乳類の幹細胞に作用する薬物の応用において調製、使用される二酸化塩素 | |
JP2014515258A5 (ja) | ||
CN109744226A (zh) | 一种免疫细胞冻存液 | |
Fernández-Romero et al. | Protective effect of NeuroEPO in the reproduction of diabetic rats. | |
ES2598627T5 (es) | Apotransferrina para el tratamiento del ictus cerebral | |
Chen et al. | In vitro and in vivo toxicology of bare and PEGylated fluorescent carbonaceous nanodots in mice and zebrafish: the potential relationship with autophagy | |
Gambito et al. | Gestational diabetes insipidus associated with HELLP syndrome: a case report | |
JP2010526068A (ja) | エリスロポエチン補完または置換 | |
JP2023534524A (ja) | 肺疾患を治療するための方法及び組成物 | |
US20220401481A1 (en) | Dosing regimens for the mobilization of hematopoietic stem and progenitor cells | |
Wu et al. | Transplantation routes affect the efficacy of human umbilical cord mesenchymal stem cells in a rat GDM model | |
Elshazzly et al. | Physiology, Newborn | |
JP6401445B2 (ja) | 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法 | |
Nasadyuk | Cell technologies in reproductology, obstetrics and gynecology | |
Yang et al. | Mesenchymal Stem Cells: A Promising Treatment for Thymic Involution | |
WO2018033033A1 (zh) | 富勒烯结构在制备治疗贫血及其并发症的药物中的应用 |